Arcadia Biosciences, Inc. RKDA
We take great care to ensure that the data presented and summarized in this overview for Arcadia Biosciences, Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in RKDA
Top Purchases
Top Sells
About RKDA
Arcadia Biosciences, Inc. produces and markets plant-based health and wellness products in the United States. It engages in developing crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company was incorporated in 2002 and is headquartered in Davis, California.
Insider Transactions at RKDA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2024
|
Thomas J. Schaefer Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+33.03%
|
$1,400
$2.06 P/Share
|
|
Aug 04
2023
|
Thomas J. Schaefer Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
649
+47.44%
|
$1,947
$3.67 P/Share
|
|
May 30
2023
|
Stanley Jacot Jr Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
5,000
+50.0%
|
$20,000
$4.31 P/Share
|
|
Feb 01
2023
|
Thomas J. Schaefer Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+20.0%
|
$0
$0.23 P/Share
|
|
Aug 01
2022
|
Pamela Haley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+12.09%
|
$0
$0.7 P/Share
|
|
Aug 03
2020
|
Pamela Haley Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
700
+20.97%
|
$2,100
$3.16 P/Share
|
|
Aug 03
2020
|
Randall Shultz Chief Technology Officer |
BUY
Open market or private purchase
|
Direct |
700
+5.11%
|
$2,100
$3.16 P/Share
|
|
Aug 03
2020
|
Matthew T Plavan Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
585
+3.93%
|
$1,755
$3.16 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 6.35K shares |
|---|